A Phase II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients with MGMT Unmethylated Glioblastoma

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Douglas Ney

Douglas Ney

Study ID

Protocol Number: 23-1257

More information available at ClinicalTrials.gov: NCT05789589

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers